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Brief Communications
Cardiothoracic surgical procedures involving extracorpo-real circulation are frequently associated with thrombo-cytopenia and thromobocytopathy. Although hemodilu-tion and consumption in combination can result in
bleeding due to procoagulant factor deficiencies, platelet loss and
dysfunction are more commonly responsible for blood loss.
Cumbersome test procedures such as bleeding time and platelet
aggregation studies do not necessarily correlate with bleeding
diatheses. Because of the unavailability of tests with rapid turn-
around time to delineate the cause of hemorrhage, various blood
components are needlessly used in an attempt to control bleeding.
This places a heavy burden on blood banks, especially during
times of a nationwide shortage in platelets.
In this communication, we are reporting the results obtained
with the platelet function analyzer (PFA-100, Dade Behring, Inc,
Deerfield, Ill) on 98 patients with or without hemorrhagic compli-
cations after undergoing coronary artery bypass grafting (CABG).
The PFA-1001 is a high shear system that challenges platelets, in
anticoagulated whole blood, to occlude an aperture cut into a
membrane coated with collagen and an agonist (epinephrine or
adenosine 5´-diphosphate, ADP). Results are expressed in seconds,
with a maximum test time of 300 seconds. This system has previ-
ously been shown to be sensitive to a variety of platelet and von
Willebrand factor defects (inherited, acquired, or drug-induced), as
well as hemorheologic factors.1-4
Patients and Methods 
Patients were screened preoperatively by prothrombin time, acti-
vated partial thromboplastin time, fibrinogen, D-dimer, complete
blood count, and platelet count for coagulation abnormalities.
Ninety-eight patients undergoing coronary artery bypass for the
first time with normal coagulation function and platelet counts and
withdrawal of aspirin or other antiplatelet drugs for at least 3 days
before the operation were enrolled. 
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Surgical procedures were performed with standard cardiopul-
monary bypass techniques at moderate systemic hypothermia
(30°C-32°C) with crystalloid pump prime. Heparin sodium was
given at an initial dosage of 3 mg/kg, supplemented to maintain the
activated clotting time at more than 400 seconds and reversed with
protamine sulfate to return activated clotting time to baseline.
Blood samples were collected in 0.109 mol/L (3.2%) trisodi-
um citrate before heparinization and 15 minutes after heparin
neutralization by protamine sulfate for measurements of coagu-
lation parameters, complete blood count, and platelets and for
PFA-100 measurements. Platelet counts and hematocrit values
in the samples obtained after heparin neutralization ranged from
64,000/µL to 202,000/µL and 29.5% to 38.2%, respectively.
Preoperative PFA-100 measurements were within normal limits
in all patients with the collagen-ADP cartridge (normal cutoff <
107 seconds).
Patients identified postoperatively as having bleeding abnor-
malities were initially treated with platelets. Persistent bleeding
(such as continuous oozing at incision sites) was treated with fresh
frozen plasma when the international normalized ratio was more
than 1.6 and with platelets when the platelet count was less than
100,000/µL. Laboratory abnormalities alone did not mandate com-
ponent therapy. Operative re-exploration was undertaken for chest
tube output greater than 300 mL in any hour or greater than 200
mL per hour for 2 successive hours.
Results and Discussion 
Of the 98 patients, 36 met the criteria for excessive bleeding. For
16 of these patients, bleeding was controlled by platelet transfu-
sion alone. For the other 20, platelet transfusion failed to control
the bleeding and other means were necessary. Retrospective analy-
sis of the data showed that PFA-100 measurements performed 15
minutes after administration of protamine were prolonged in 15 of
the 16 patients (Table 1) whose bleeding was controlled by platelet
transfusion only. This was in sharp contrast to the group without
bleeding abnormalities (6 of 62 had long PFA-100 measurements)
and to the group of patients that required more than platelets to
control bleeding, only 3 of 20 having prolonged PFA-100 mea-
surements (Figure 1). Platelet counts alone were inadequate for
identifying which patients with bleeding abnormalities would
respond to platelet transfusion (Table 1). In contrast, the sensitivi-
ty and specificity of the PFA-100 system for identifying response
to platelet transfusion were 94% and 85%, respectively. These
observations suggest a potential for PFA-100 measurements to
help identify which patients could benefit the most from platelet
transfusion if bleeding complications follow a CABG procedure.
This observation is in concordance with Slaughter and coworkers,5
who reported that 80% of patients having CABG with abnormal
chest tube output had prolonged PFA-100 measurements 15 min-
utes after administration of protamine.
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Conclusions 
Our study involving a small number of patients suggests that use
of the PFA-100 system to monitor platelet functional status is ben-
eficial in cardiothoracic surgical procedures involving extracorpo-
real circulation. Specifically, had the PFA-100 system been used to
direct postoperative transfusion in patients with bleeding prob-
lems, 50% of these patients would have been spared platelets with
an accuracy of 94% (17/18). The simplicity of the procedure,
which enables the test to be performed on-site, the lack of signifi-
cant preanalytical variables, and the rapid turnaround time make
this instrument an ideal tool for this purpose.
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Figure 1. Correlation between closure times and the bleeding classification of 98 patients having CABG: PFA-100
measurements were obtained on 3.2% citrated blood samples tested with the collagen-ADP cartridge. Similar
results were obtained with the collagen-epinephrine cartridge (results not shown). The shaded box indicates the
normal range for collagen-ADP determined on 105 ostensibly normal donors (59-107 seconds).
TABLE 1.  Sensitivity and specificity of platelet counts and PFA-100 measurements
Type of bleeding abnormality Platelet count PFA-100
PR (n = 16) 56% sensitivity (9/16) 94% sensitivity (15/16)
PNR (n = 20) 55% specificity (11/20) 85% specificity (17/20)
Sensitivity and specificity of platelet counts and PFA-100 measurements (collagen-ADP cartridge) for identifying patients with bleeding abnormalities that
were responsive to platelets (PR) and those that were not (PNR). Platelet counts were considered abnormal if less than 100,000/µL. PFA-100 results were
considered abnormal if the aperture occlusion time was more than 107 seconds.
